HCV Genotype Distribution Among People Who Inject Drug in Turkey: Findings from Multicenter and Cross-Sectional Study.  Dilbaz N, Kuloğlu M, Evren EC, Paltun SC, Bilici R, Noyan CO, Kulaksizoglu B, Karabulut V, Umut G, Unubol B, Ucbilek E.&n...

Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study.  Grebely J, Gilliver R, McNaug...

Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study Isfordink, Cas J et al. The Lancet Public Health, Volume 8, Issue ...

HCV treatment initiation in the era of universal direct acting antiviral coverage - Improvements in access and persistent barriers.  Jiang N, Bruneau J, Makarenko I, Minoyan N, Zang G, Høj SB, Larney S, Martel-Laferrière V.  Int J Drug...

Need for integration of hepatitis C (HCV) services in community-based settings for people who inject drugs: results from a global values and preferences survey.  Di Ciaccio M, Villes V, Perfect C, El Kaim JL, Donatelli M, James C, Easterbroo...

Improved health-related quality of life after hepatitis C viraemic clearance among people who inject drugs may not be durable.  McDonald, SA, Myring, G, Palmateer, NE, et al.  Addiction. 2023: 000– 000. doi.org...